SpringerPlus

Table 1 The baseline demographic and clinical characteristics of the study group

From: Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease

Descriptive parameter	Range	Mean ± S.D
Age	16-85 years	48.26 ± 17.91
Disease duration	1-20 years	7.29 ± 3.93
ESR	8-119 mm/hr	51.00 ± 25.30
CRP	6-136.50 mg/l	35.18 ± 31.65
Hemoglobin	10-16gm/dl	11.56 ± 1.30
Rheumatoid factor	0-849	141.09 ± 157.88
Anti-CCP	0-450	230.05 ± 156.35
DAS	3-7.5	6.0 ± 1.0
HAQ	0.5-8	1.30 ± 0.71
VAS	5-10	6.70 ± 0.95
Medications:	Number of patients	Percentage%
Conventional DMARDs	58	72.5
Methotrexate	64	80
Oral corticosteroids	53	66.2
Non-steroidal drugs	80	100

Abbreviations: ESR: erythrocyte sedimentation rate, CRP: C- reactive protein, Anti-CCP: anti-citrullinated C peptide, DAS-28: disease activity score, HAQ: health assessment questionnaire, VAS: visual analogue scale for pain.

Back to article page